Reduction, refinement and replacement of animal use in toxicity testing: an overview

Authors

  • Karen Cristine Ceroni Cazarin Universidade Estadual de Campinas; Faculdade de Ciências Médicas; Departamento de Medicina Preventiva e Social
  • Cristiana Leslie Corrêa Pontifícia Universidade Católica de Campinas; Faculdade de Ciências Farmacêuticas; Centro de Ciências da Vida
  • Flávio Ailton Duque Zambrone Universidade Estadual de Campinas; Faculdade de Ciências Médicas; Departamento de Medicina Preventiva e Social

DOI:

https://doi.org/10.1590/S1516-93322004000300004

Keywords:

Three Rs Program, Alternative methods, Experimental animals, Toxicity testing

Abstract

Toxicity assessment is the process of predicting the adverse effects that may be caused to an organism by exposuring it to a given chemical and, for regulation purposes, the most used model in toxicity testing is the animal. However, in today's society the use of animals has become a subject of much public health due to the large number of animals used as well as the pain and distress caused, mainly related to acute toxicity testing. The concept of the "Three Rs" - reduction, refinement, and replacement of animal use - emerged as a mean of removing inhumanity from animal experimentation and aiming to lower the number of animals used, in order to decrease the incidence or severity of inhumane procedures and to find alternative procedures to replace in vivo testing. Many alternative toxicological tests have already been implemented, even knowing that this process is very complex and need to be extensively validated and accepted by regulatory bodies. This paper presents an overview on several aspects of the "Three Rs", including historical evolution and implementation and validation of alternative methods, emphasizing its application on toxicity testing and in global harmonization.

Downloads

Download data is not yet available.

Published

2004-09-01

Issue

Section

Reviews

How to Cite

Reduction, refinement and replacement of animal use in toxicity testing: an overview. (2004). Revista Brasileira De Ciências Farmacêuticas, 40(3), 289-299. https://doi.org/10.1590/S1516-93322004000300004